ClinicalTrials.Veeva

Find clinical trials for Prostate Cancer in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Rochester, MN, USA:

Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients

effectiveness of the NanoKnife System when used to ablate localized prostate cancer in intermediate risk subjects with organ-confin ...

Active, not recruiting
Prostate Cancer
Device: NanoKnife Procedure
AngioDynamics
AngioDynamics

Rochester, Minnesota, United States and 1 other location

of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with metastatic castration-resistant prostate...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Biological: vudalimab monotherapy
Combination Product: vudalimab + olaparib

Phase 2

Xencor
Xencor

Rochester, Minnesota, United States and 16 other locations

of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...

Enrolling
Prostate Cancer
Device: Vanquish System
Francis Medical

Rochester, Minnesota, United States and 29 other locations

This study evaluates the diagnostic performance and safety of [18F]PSMA-1007 PET/CT imaging in patients with suspected recurrence of prostate...

Active, not recruiting
Prostate Cancer Recurrent
Prostate Cancer
Drug: [18F]PSMA-1007

Phase 3

ABX Advanced Biochemical Compounds

Rochester, Minnesota, United States and 5 other locations

This is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate ca...

Active, not recruiting
Prostate Cancer Metastatic Castration-Resistant
Stage IV Prostate Cancer
Drug: Abiraterone Acetate
Drug: Prednisone

Phase 2

Northwestern University
Northwestern University

Rochester, Minnesota, United States and 17 other locations

The purpose of this study is to establish the maximum tolerable dose of niraparib when combined with prostate stereotactic body radiotherapy...

Enrolling
Prostate Cancer
Radiation: Stereotactic body radiotherapy (SBRT)
Drug: Abiraterone Acetate

Phase 1, Phase 2

University of Michigan Rogel Cancer Center

Rochester, Minnesota, United States and 5 other locations

hormonal therapy (NHT) in men with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with on ...

Active, not recruiting
Metastatic Prostate Cancer
Prostate Adenocarcinoma
Drug: Cabozantinib
Drug: Abiraterone Acetate

Phase 3

Exelixis
Exelixis

Rochester, Minnesota, United States and 272 other locations

The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned t...

Active, not recruiting
Prostate Cancer
Drug: Bicalutamide
Drug: TAK-700

Phase 3

SWOG Cancer Research Network

Rochester, Minnesota, United States and 559 other locations

prednisone in treating patients with castration-resistant metastatic prostate cancer. Androgens can cause the growth of prostate...

Active, not recruiting
Hormone-resistant Prostate Cancer
Stage IV Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 3

Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology

Rochester, Minnesota, United States and 538 other locations

The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA...

Enrolling
Metastatic Castration-Sensitive Prostate Cancer
Drug: Abiraterone Acetate
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Rochester, Minnesota, United States and 394 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems